CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan's Top Pharmaceutical Companies

Corporate Breaking News

Home : CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan's Top Pharmaceutical Companies

Sep 30 2021	CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan's Top Pharmaceutical Companies
TOKYO and TEL AVIV, Israel, Sept. 30, 2021 /PRNewswire/ -- CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summit Pharmaceuticals International (SPI), a Japanese company providing service and products to the pharmaceutical...


Source:https://www.prnewswire.com:443/news-releases/cytoreason-and-summit-pharmaceuticals-international-announce-the-introduction-of-an-ai-platform-to-one-of-japans-top-pharmaceutical-companies-301388351.html

Related News
» Gallium Arsenide (GaAs) Wafers Market Size Worth 2.73 Million Tons\| Increasing adoption of Smartphones to Accelerate the market growth \| Technavio » TDH Holdings, Inc. Announces Entry into Agreement for Registered Direct Placement of $9.1 Million of Common Shares and Warrants